CXCL13 and infectious encephalitis: The subgroup analysis results are only available for the infectious encephalitis group, which, similar to the overall effect, does not implicate any significant alteration in CXCL13 concentration (SMD, -0.52; 95% CI, -2.13–1.10; P = 0.53).